41.3 F
New York
Friday, October 30, 2020

The Unprecedented Rise of Titan Pharmaceuticals Inc. (NASDAQ:TTNP)

Must read

Boston Scientific Corporation (NYSE:BSX) Stock is Plummeting, Here is Why

Boston Scientific Corporation (BSX) shares are trading at lower $33.50 and the avg recommendation for the stock is Strong Buy, while the current analyst...

The Rejuvenation of Facebook Inc. (NASDAQ:FB)

Facebook Inc. (FB) shares are trading at higher $280.83 and the avg recommendation for the stock is Strong Buy, while the current analyst price...

Is Now the Time to Invest in Intel Corporation (NASDAQ:INTC)?

Intel Corporation (INTC) shares are trading at lower $44.11 and the avg recommendation for the stock is Hold, while the current analyst price target...

Renewed Optimism is Surrounding Marathon Oil Corporation (NYSE:MRO)

Marathon Oil Corporation (MRO) shares are trading at higher $3.99 and the avg recommendation for the stock is Moderate Buy, while the current analyst...

Titan Pharmaceuticals Inc. (TTNP) shares are trading at lower $0.20 and the avg recommendation for the stock is Moderate Buy.

To add more color to this target, the company’s high over the last year is $0.59 and the low is $0.14. Over the last 52 weeks, TTNP is down -50.52% while the S&P 500 is up 11.54%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, TTNP reported a profit of $1.1 million. Titan Pharmaceuticals Inc. also saw revenues increase to $1.32 million. In addition, TTNP has free cash flow of -$9.28 million as of 06-2020. The company’s EBITDA came in at -$4.32 million which compares well with its peers.

TTNP Return on Assets is -179.30%. All told, it is clear that, TTNP needs to be on your watchlist.

Find out when TTNP reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. TTNP has a short ratio of 1.03 and outstanding shares of 95.66M.

Company Outlook

TTNP has seen increased volume after this news and investors are putting their support behind the value proposition. Traders will also note the company’s earnings per share came in at -0.38. Titan Pharmaceuticals Inc. TTNP also noted assets of $9.76 million at the end of the last quarter. Investors should also keep an eye on sector updates as TTNP has historically followed its peers on positive news.

All told, Titan Pharmaceuticals Inc. TTNP has strung together solid data and demonstrated underlying fundamentals. At its current valuation, TTNP represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

Titan Pharmaceuticals Inc. TTNP is now commanding a market cap of 19.88M and a float of 95.38M. TTNP is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of TTNP stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in TTNP, either long or short, and we have not been compensated for this article.

Latest article

The Rejuvenation of The Coca-Cola Company (NYSE:KO)

The Coca-Cola Company (KO) shares are trading at higher $48.02 and the avg recommendation for the stock is Moderate Buy, while the current analyst...

Barrick Gold Corporation (NYSE:GOLD) Recent Earnings Shows Major Promise

Barrick Gold Corporation (GOLD) shares are trading at higher $26.17 and the avg recommendation for the stock is Moderate Buy, while the current analyst...

The Unprecedented Rise of VEREIT Inc. (NYSE:VER)

VEREIT Inc. (VER) shares are trading at higher $6.19 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...

Schlumberger Limited (NYSE:SLB) Finding Strong Support

Schlumberger Limited (SLB) shares are trading at higher $14.45 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...

Renewed Optimism is Surrounding Visa Inc. (NYSE:V)

Visa Inc. (V) shares are trading at higher $184.87 and the avg recommendation for the stock is Strong Buy, while the current analyst price...